Dabrafenib (GSK2118436)

Catalog No.S2807

Dabrafenib (GSK2118436) Chemical Structure

Molecular Weight(MW): 519.56

Dabrafenib (GSK2118436) is a mutant BRAFV600 specific inhibitor with IC50 of 0.8 nM in cell-free assays, with 4- and 6-fold less potency against B-Raf(wt) and c-Raf, respectively.

Size Price Stock Quantity  
In DMSO USD 180 In stock
USD 90 In stock
USD 130 In stock
USD 170 In stock
USD 270 In stock
USD 400 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

5 Customer Reviews

  • A375P cells were treated with vehicle, the BRAF inhibitor GSK2118436, the MEK inhibitor GSK1120212, 10 uM HCQ, or the indicated combinations. Shown are 48-hour immunoblots directed against the indicated proteins.

    J Clin Invest 2014 24(3), 1406-17. Dabrafenib (GSK2118436) purchased from Selleck.

    Levels of pERK and tERK in the CLL cells derived from PBMC were measured by Western blot. We used vemurafenib, dabrafenib, and trametinib (0.07 uM) as indicated. One of 3 independent experiments with similar results is shown. CLL cells exposed to dabrafenib or vemurafenib had an elevated pERK/tERK ratio as compared with vehicle (P < 0.01).

    J Clin Invest 2014 124(11), 5074-84. Dabrafenib (GSK2118436) purchased from Selleck.

  • The effects of inhibitors of mutant BRAFV600 inhibitor dabrafenib on cancer cell growth were evaluated by the MTT assay. Cell growth inhibition of FRO and SW1736 cell lines induced by dabrafenib.

    Transl Res 2014 10.1016/j.trsl.2014.06.005. Dabrafenib (GSK2118436) purchased from Selleck.

    Dabrafenib alleviates acetaminophen-induced hepatotoxicity in mice. Mice were treated with 300 mg/kg acetaminophen (i.p.), with or without pretreatment with 300 mg/kg or 100 mg/kg dabrafenib (p.o.).TUNEL staining for nuclear DNA fragmentation in mouse liver cells.

    Cell Death Dis 2014 5, e1278. Dabrafenib (GSK2118436) purchased from Selleck.

  • Western blot analysis of p-Erk and total ERK in A375 melanoma cell line after treatment with different doses of Dabrafenib for 48 hours (A). p-ERK signal was normalized with total ERK signal (B), SD and means of the normalized p-ERK values were reported.

    PLoS One, 2016, 11(3):e0152104. Dabrafenib (GSK2118436) purchased from Selleck.

Purity & Quality Control

Choose Selective Raf Inhibitors

Biological Activity

Description Dabrafenib (GSK2118436) is a mutant BRAFV600 specific inhibitor with IC50 of 0.8 nM in cell-free assays, with 4- and 6-fold less potency against B-Raf(wt) and c-Raf, respectively.
Targets
B-Raf (V600E) [1]
(Cell-free assay)
B-Raf [1]
(Cell-free assay)
C-Raf [1]
(Cell-free assay)
0.8 nM 3.2 nM 5.0 nM
In vitro

Dabrafenib is selective for Raf kinase, with 400 fold selectivity towards B-Raf over 91% of the other kinases tested. Dabrafenib inhibits B-RafV600E kinase, leading to decreased ERK phosphorylation and inhibition of cell proliferationby an initial arrest in the G1 phase of the cell cycle in cancer cells that specifically encode the mutation for B-RafV600E. [1]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
M4m4ZWtqdmG|ZTDBd5NigQ>? NY\mfGFKUW6qaXLpeIlwdiCxZjDOMZRmem2rbnHsJGhqeyC2YXfn[YQhSi2UYX[gWlYxOEVibYX0ZY51KGW6cILld5Nm\CCrbjDiZYN2dG:4aYL1d{Bqdm[nY4Tl[EBqdnOnY4SgZ4VtdHNiY3:t[ZhxemW|c3nu[{BETEN|NzDhd5Nme3OnZDDhd{Bl\WO{ZXHz[UBqdiCkaX;0bY56dGG2ZXStUWVMKHC{b4TlbY4heGixc4Doc5J6dGG2aX;uJIJ6KEGucHjhV4Nz\WWwIHHzd4F6KHerdHigTWM2OCCxZjCwMlAxODdizszN MlT5NlQ6ODB4N{O=
SK-MEL-28 NV7mOlk2U2mwYYPlJGF{e2G7 MUSxJIg> MVHJcohq[mm2aX;uJI9nKEJvUnHmJHY3ODCHIH31eIFvfCCrbjDoeY1idiCVSz3NSWwuOjhiY3XscJMh[XO|ZYPz[YQh[XNiZHXjdoVie2ViaX6gSXJMKHCqb4PwbI9zgWyjdHnvckB4cXSqIFnDOVAhd2ZiMD6wNFQh|ryP NXzwSGpzOjR7MEC2O|M>
HepG2 NVrHWGNUU2mwYYPlJGF{e2G7 MXjJcohq[mm2aX;uJI9nKEJvUnHmJHY3ODCHIH31eIFvfCCrbjDoeY1idiCKZYDHNkBk\WyuczDhd5Nme3OnZDDhd{Bl\WO{ZXHz[UBqdiCHUlugdIhwe3Cqb4L5cIF1cW:wIIfpeIghUUN3MDDv[kAxNjByNDFOwG0> MlLxNlQ6ODB4N{O=
COLO205 M{OxRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVS5cVhFUW6qaXLpeIlwdiCxZjDoeY1idiCFT1zPNlA2KGOnbHygdJJwdGmoZYLheIlwdiC5aYToJGlEPTBib3[gNE4xODdizszN M2DKcFI1QTByNkez
HepG2 M2P3SWZ2dmO2aX;uJGF{e2G7 MorCOFUhdWmw MVXEUXNQ NXTwfpBkUW6qaXLpeIlwdiCxZjDBcIs2KGmwIGTHSk1j\XSjLYP0bY12dGG2ZXSgbJVu[W5iSHXwS|Ih[2WubIOgZZN{\XO|ZXSgZZMh\GWlcnXhd4UhcW5iU33h[FIheGixc4Doc5J6dGG2aX;uJJRz\WG2ZXSg[o9zKDR3IH3pcpMheHKrb4KgeI8hXEeILXLleIEhe3SrbYXsZZRqd25ibXXhd5Vz\WRiYX\0[ZIhPjBibXnud{BjgSCxZInzd4V6KGKub4Sgd4Nidm6ncjDhcoFtgXOrczD3bZRpKEmFNUCgc4YhOy55IN88US=> NWDVbmtWOjR7MEC2O|M>
HFF MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1LNeVExKM7:TR?= NEfrbYc4OiCq MmX6SG1UVw>? MmnoTY5pcWKrdHnvckBw\iCycn;sbYZmemG2aX;uJI9nKGi3bXHuJGhHTiClZXzsd{Bp[XKkb4Lpcochf2muZDD0fZBmKEJvUnHmJJdqfGhiSVO1NEBw\iB|IN88US=> M2HCc|I{QDR2MEO4
SK-MEL-28 M1yyeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NETDdZgyOCEQvF2= NVHKPJNTPzJiaB?= MljoSG1UVw>? NEXqcVJKdmirYnn0bY9vKG:oIFKtVoFnKFZ4MEDFJI12fGGwdD3kdol3\W5iU1utUWVNNTJ6IHPlcIwheHKxbHnm[ZJifGmxbjD3bZRpKEmFNUCgc4YhOC5yNEOg{txO Mn\ONlM5PDRyM{i=
A375P-F11 NYjqOnFZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVy1UpZPOTBizszN NITKWlQ4OiCq M4q3TmROW09? MnTDTY5pcWKrdHnvckBw\iCELWLh[kBXPjByRTDteZRidnRvZILpeoVvKEF|N{XQMWYyOSClZXzsJJBzd2yrZnXyZZRqd25id3n0bEBKSzVyIH;mJFAvODdzIN88US=> M{OxeVI{QDR2MEO4
MALME-3M MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHPqbnQyOCEQvF2= M2jGRVczKGh? M2rnOWROW09? NInibFlKSzVyPUGgcm0> NXOxe3Q2OjN6NESwN|g>
UACC-62 MnniS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3npPFExKM7:TR?= MXe3NkBp MYXEUXNQ MV3JR|UxRTFibl2= MXyyN|g1PDB|OB?=
C32TG NUfzWJZoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlL5NVAh|ryP M2TCelczKGh? MV7EUXNQ M2Hxe2lEPTB;MTDuUS=> NH\4ZlczOzh2NECzPC=>
SK-MEL-1 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mkf5NVAh|ryP M1jhNlczKGh? NWG3U5k3TE2VTx?= NGjPUGlKSzVyPUKgcm0> NGHuT3kzOzh2NECzPC=>
M14 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWWxNEDPxE1? NVXP[YU{PzJiaB?= NVTxc2pCTE2VTx?= NFLjZ5JKSzVyPUKgcm0> NEfPOXQzOzh2NECzPC=>
SK-MEL-28 M3j4S2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV:xNEDPxE1? MmLVO|IhcA>? MoDLSG1UVw>? NFK3bY9KSzVyPUOgcm0> MWWyN|g1PDB|OB?=
A375 M1Pxbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlvlNVAh|ryP MWe3NkBp MnrLSG1UVw>? NULKcFNSUUN3ME20JI5O NI[zelUzOzh2NECzPC=>
DU-4475 Mn;kS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1nFdVExKM7:TR?= NX;s[2hrPzJiaB?= NIHvZ3FFVVOR NHHtdoZKSzVyPUWgcm0> NX;uU2VpOjN6NESwN|g>
UACC-257 MmXqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFzEfJAyOCEQvF2= NGTXZZo4OiCq NWnUSW1bTE2VTx?= Mo\sTWM2OD14IH7N MlfONlM5PDRyM{i=
Colo 205 MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2m4VlExKM7:TR?= NXjabWl2PzJiaB?= NInIc4pFVVOR NH7VeYJKSzVyPUegcm0> NFK5T5kzOzh2NECzPC=>
SK-MEL-3 NVPmfHV7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWXpfWUxOTBizszN M3jKUVczKGh? M{LW[WROW09? MWHJR|UxRTdibl2= M1LjUlI{QDR2MEO4
SH-4 NVjmVZhST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlXVNVAh|ryP Mm\xO|IhcA>? NFzDZ|ZFVVOR NIPJTXJKSzVyPUigcm0> MYmyN|g1PDB|OB?=
A101D MoTnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYSxNEDPxE1? MYK3NkBp NF;YPJVFVVOR NHjpTXhKSzVyPUmgcm0> NYOyTJRPOjN6NESwN|g>
ES-2 M1T1N2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYfzOotwOTBizszN NGTLT|A4OiCq NX\aNoN1TE2VTx?= NV;xZmxHUUN3ME21N{BvVQ>? NUK1O4hyOjN6NESwN|g>
HT-29 MmfHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXXtXHNEOTBizszN MXi3NkBp NIm5XmhFVVOR MnXvTWM2OD14NjDuUS=> NELNR44zOzh2NECzPC=>
SW1417 NEP0VY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4WzW|ExKM7:TR?= NVX5d5VEPzJiaB?= MYjEUXNQ M4fMZWlEPTB;MUW4JI5O M1v6dVI{QDR2MEO4
SW872 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVmxNEDPxE1? NYTnNHQ4PzJiaB?= NWrGV2RoTE2VTx?= MVTJR|UxRTN5NzDuUS=> MmTpNlM5PDRyM{i=
RKO NIjnUlNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3[1R|ExKM7:TR?= NVGxXVNyPzJiaB?= MlzYSG1UVw>? NGTE[2pKSzVyPUKuOVIzKM7:TR?= M3;p[lI{QDR2MEO4
A673 M{HPdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlzJNVAh|ryP M2nCNlczKGh? Mly2SG1UVw>? NXT4V|lLUUN3ME2xNEDPxE1? NE\neIwzOzh2NECzPC=>
GCT M3zSUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVH4W21MOTBizszN MorSO|IhcA>? NFv3SpRFVVOR Mo\UTWM2OD1zMDFOwG0> M4T4[lI{QDR2MEO4
WM-115 MkfNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUKxNEDPxE1? MoDhO|IhcA>? MmPOSG1UVw>? MmjOTWM2OD13IH7N M4D5NFI{QDR2MEO4
YUMAC M3LNNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYCxNEDPxE1? NHvkTmc4OiCq MWjEUXNQ NYTjeJFIUUN3ME21JI5O NE\GV|UzOzh2NECzPC=>
OV-90 M{TRbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXKxNEDPxE1? M{\5OlczKGh? NIHXVpVFVVOR MUHJR|UxRTJ7IH7N MnLYNlM5PDRyM{i=
NCI-H508 M3jFU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF;0UG8yOCEQvF2= NX:4XHVpPzJiaB?= NYrFcIVITE2VTx?= Mnm4TWM2OD1zMDFOwG0> M{LqeFI{QDR2MEO4
MDA-MB-231 NWn3XHp7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnzlNVAh|ryP M3nKdFczKGh? M3X4dWROW09? Ml;VTWM2OD1zMDFOwG0> NVLwc5ZOOjN6NESwN|g>
SW756 NF\5T5pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV\0Z4pbOTBizszN NH3CZZM4OiCq MVPEUXNQ M4TpdWlEPTB;MUCg{txO NHjYPWozOzh2NECzPC=>
SW-837 NUXaRZh7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2LrUFExKM7:TR?= MXq3NkBp NUi2NVM1TE2VTx?= NXLUWYFvUUN3ME2xNEDPxE1? NV;pdFNqOjN6NESwN|g>
UMUC-3 NVjre28zT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIj3OY0yOCEQvF2= NEjZTY04OiCq NY\hTHBoTE2VTx?= NGroUFlKSzVyPUGwJO69VQ>? MXyyN|g1PDB|OB?=
LS-174T MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NE\WZVcyOCEQvF2= MYe3NkBp M1jMT2ROW09? NXjDfopPUUN3ME2xNEDPxE1? NX60W4ZKOjN6NESwN|g>
A549 NEe2NXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1i4cVExKM7:TR?= M3XhZVczKGh? M2\2OmROW09? NFPi[YJKSzVyPUGwJO69VQ>? NH;mcXQzOzh2NECzPC=>
SHP-77 NXLScJM4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4n6NFExKM7:TR?= NVr4OWR6PzJiaB?= NV25[|RyTE2VTx?= MWrJR|UxRTFyIN88US=> M{[1NVI{QDR2MEO4
SW480 M2ToNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnzONVAh|ryP M4fBclczKGh? Mn61SG1UVw>? MnnsTWM2OD1zMDFOwG0> NGD4bYIzOzh2NECzPC=>
DLD-1 MmnlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXmxNEDPxE1? MV23NkBp NV7PNXdGTE2VTx?= NEPCXYxKSzVyPUGwJO69VQ>? NFzQb5YzOzh2NECzPC=>
HCT-116 NXPrdJQxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUmxNEDPxE1? NI[5R4Y4OiCq M1W1NWROW09? MXHJR|UxRTFyIN88US=> M3fqTFI{QDR2MEO4
NCI-H747 Mnm5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXjOeZZjOTBizszN MnrUO|IhcA>? MV\EUXNQ MYjJR|UxRTFyIN88US=> NITiOI0zOzh2NECzPC=>
T-84 MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoTPNVAh|ryP MmexO|IhcA>? M3TWW2ROW09? NF\QOoRKSzVyPUGwJO69VQ>? M3\lNFI{QDR2MEO4
NCI-H460 MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmPCNVAh|ryP MX[3NkBp NXLlN5lHTE2VTx?= NGPBd49KSzVyPUGwJO69VQ>? MkG5NlM5PDRyM{i=
Calu-6 NHS5ephIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUTSTJhkOTBizszN MXe3NkBp MYPEUXNQ MmHWTWM2OD1zMDFOwG0> MXiyN|g1PDB|OB?=
HCC-2998 MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGnpc5EyOCEQvF2= M3LifFczKGh? MoK1SG1UVw>? M3n5PWlEPTB;MUCg{txO NHXhe4EzOzh2NECzPC=>
LS1034 MmXHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlvmNVAh|ryP MkPXO|IhcA>? NYrIOoo3TE2VTx?= MnXVTWM2OD1zMDFOwG0> NFHUV2IzOzh2NECzPC=>
CHP-212 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3rx[|ExKM7:TR?= NGGx[ms4OiCq NWfVV48yTE2VTx?= MmT6TWM2OD1zMDFOwG0> MoDLNlM5PDRyM{i=
SK-N-AS NF;OSnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml7YNVAh|ryP Mnf0O|IhcA>? M1zpfmROW09? MYPJR|UxRTFyIN88US=> MnzENlM5PDRyM{i=
BFTC-905 NEPTNZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NG\nNW4yOCEQvF2= NHnwZm84OiCq M{DDTWROW09? MVHJR|UxRTFyIN88US=> M3W3PVI{QDR2MEO4
HuT78 M2PtSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV;mWmNFOTBizszN NHTCcWM4OiCq NWWzWpJWTE2VTx?= NHnBVHFKSzVyPUWyJI5O MkT3NlM5PDRyM{i=
RPMI-8226 NYTGe4ZpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1GzcVExKM7:TR?= M3XOeVczKGh? M3XXVmROW09? NWXBSnJxUUN3ME2yOlMhdk1? MnG4NlM5PDRyM{i=
BC-3 MnXzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYWxNEDPxE1? NETGRXo4OiCq M1vVZmROW09? NHHkPVFKSzVyPUK3O{BvVQ>? M3uwZVI{QDR2MEO4
ACHN NF;KWG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXzycnM5OTBizszN M{jiU|czKGh? NWDJdIl3TE2VTx?= NWPoZXE4UUN3ME2yPVQhdk1? MlnvNlM5PDRyM{i=
JRT3-T35 M{GyPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnXENVAh|ryP M2i5PFczKGh? NHL1XZJFVVOR M1P1UmlEPTB;Mkm1JI5O MVOyN|g1PDB|OB?=
SK-MES-1 Ml3wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoDKNVAh|ryP NX;YXXp7PzJiaB?= MXrEUXNQ NYDBR|hiUUN3ME2zNlkhdk1? MXKyN|g1PDB|OB?=
CESS NInaS4hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1vDfVExKM7:TR?= NUDjSW9MPzJiaB?= Mn3YSG1UVw>? NXX4fFBWUUN3ME20PVchdk1? MWiyN|g1PDB|OB?=
H4 M1\SN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFLQT|MyOCEQvF2= Mk[1O|IhcA>? NETBU5pFVVOR NGHu[oxKSzVyPU[xPUBvVQ>? M{fydFI{QDR2MEO4
BC-1 M1W4dGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{\YVVExKM7:TR?= MWq3NkBp M3zNZmROW09? NY[3UWhNUUN3ME23NFQhdk1? NIfLTJczOzh2NECzPC=>
DB NIjlT|JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2PKelExKM7:TR?= MlvwO|IhcA>? Mm\HSG1UVw>? NVLXT41SUUN3ME24O|Mhdk1? M{LKS|I{QDR2MEO4
RPMI-6666 NHHVRo1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVzVUnhbOTBizszN MVS3NkBp NHTZNWFFVVOR MlniTWM2OD17Mkigcm0> MlfwNlM5PDRyM{i=
MC/CAR NFPlO5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4HxSFExKM7:TR?= NIOzbGY4OiCq MXHEUXNQ MoW4TWM2OD1zLkCwNkDPxE1? MmnVNlM5PDRyM{i=
SNU-1 M3jDdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWfMZ2I2OTBizszN M{HhcVczKGh? MV;EUXNQ M4PlW2lEPTB;MT61NFEh|ryP Mmr2NlM5PDRyM{i=
CEM/C1 M1iwRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmPvNVAh|ryP M1rmUlczKGh? MWLEUXNQ MVfJR|UxRTFwN{ezJO69VQ>? M1v5eFI{QDR2MEO4
GDM-1 NYnlb3gzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWKxNEDPxE1? NHj2cXg4OiCq M2nZT2ROW09? NGLXfGxKSzVyPUGuPVk4KM7:TR?= NGrQZlIzOzh2NECzPC=>
HT-1080 NILGdJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXT0dnozOTBizszN NY\ESVNCPzJiaB?= MoDJSG1UVw>? NVjBVVhLUUN3ME2yMlAxPCEQvF2= MYeyN|g1PDB|OB?=
HL-60 NYTiNWRVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1TkflExKM7:TR?= NXfUbW1OPzJiaB?= NEOyZmVFVVOR NEm5TVRKSzVyPUKuNVc5KM7:TR?= Mmn1NlM5PDRyM{i=
C3A MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVzl[GR7OTBizszN NWXMSVBqPzJiaB?= MVjEUXNQ NFL1UGdKSzVyPUWuOFE1KM7:TR?= MXiyN|g1PDB|OB?=
MES-SA MmPVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mo[yNVAh|ryP MojQO|IhcA>? NUDEToZxTE2VTx?= MnXtTWM2OD14Lkm4PUDPxE1? MWeyN|g1PDB|OB?=
22Rv1 NFHRcmlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MorlNVAh|ryP MkLYO|IhcA>? M3jLXGROW09? NUXWc|NYUUN3ME2xNEDPxE1? Mn;CNlM5PDRyM{i=
647-V NGqwU2RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV[zZ|hGOTBizszN M2W4b|czKGh? MUDEUXNQ NYnUUGdvUUN3ME2xNEDPxE1? M4j4N|I{QDR2MEO4
786-O NX;RXVBMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVyxNEDPxE1? NET5WGE4OiCq M{Ptc2ROW09? MkTsTWM2OD1zMDFOwG0> M4TFNlI{QDR2MEO4
A172 MnzzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIDxbowyOCEQvF2= MV[3NkBp NXnhfZVRTE2VTx?= M121d2lEPTB;MUCg{txO MX[yN|g1PDB|OB?=
A204 NFL3O3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUOxNEDPxE1? MorvO|IhcA>? MWrEUXNQ NXHRfYFuUUN3ME2xNEDPxE1? MoK3NlM5PDRyM{i=
A427 M17yTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH\ReoYyOCEQvF2= NWfvZVd[PzJiaB?= NEHUNYdFVVOR NGTHO|lKSzVyPUGwJO69VQ>? MWmyN|g1PDB|OB?=
A431 NYjVdFBxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NG\JSJAyOCEQvF2= M{LoNVczKGh? MUPEUXNQ M2G2U2lEPTB;MUCg{txO NXr5bmpEOjN6NESwN|g>
A2780 M1i3c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH[yW3kyOCEQvF2= NUXyRpN[PzJiaB?= NYL2W|lsTE2VTx?= M3K3OWlEPTB;MUCg{txO M17n[FI{QDR2MEO4
ARH-77 NUHuflI2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NX7hTXhYOTBizszN MknSO|IhcA>? M{PZV2ROW09? MUPJR|UxRTFyIN88US=> Mlj6NlM5PDRyM{i=
Be(2)C MlPXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXrnVIJzOTBizszN M1G5VFczKGh? Mo\iSG1UVw>? M4\nb2lEPTB;MUCg{txO NEfNT|UzOzh2NECzPC=>
BT-20 NGHTWYFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUfp[mpNOTBizszN NEjxbmY4OiCq M4DjR2ROW09? M{SyXWlEPTB;MUCg{txO NXqwNY9mOjN6NESwN|g>
BxPc3 NEnqUWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYrtN3Q1OTBizszN M1PvTVczKGh? MnHQSG1UVw>? Mn[3TWM2OD1zMDFOwG0> M3mzU|I{QDR2MEO4
C-4 I NIrqOGJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1TrWFExKM7:TR?= MlvsO|IhcA>? Ml7kSG1UVw>? NEjib49KSzVyPUGwJO69VQ>? M1jpb|I{QDR2MEO4
C33A MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NITC[JAyOCEQvF2= NH;PPWQ4OiCq NIHKfodFVVOR NXSzWWN4UUN3ME2xNEDPxE1? MUeyN|g1PDB|OB?=
CAL-27 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVL6UGp{OTBizszN NHPtXXU4OiCq MVTEUXNQ M1mxT2lEPTB;MUCg{txO MYiyN|g1PDB|OB?=
CAL-62 NF[4NXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1HPb|ExKM7:TR?= MYq3NkBp NWrCfVQ{TE2VTx?= NXX2PGhHUUN3ME2xNEDPxE1? NH\EWHIzOzh2NECzPC=>
Calu-3 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYHtc5FQOTBizszN M4H3TVczKGh? NVXaWJB1TE2VTx?= Mn3qTWM2OD1zMDFOwG0> NEnCNIIzOzh2NECzPC=>
CaOV3 NYXKRXB2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUGxNEDPxE1? Mnj5O|IhcA>? NVXDZVdqTE2VTx?= NFj0ZVJKSzVyPUGwJO69VQ>? M4rSTFI{QDR2MEO4
CGTHW1 NIXqT|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVfQPVN4OTBizszN MXe3NkBp NHfZRnlFVVOR NYOx[4MzUUN3ME2xNEDPxE1? Ml7JNlM5PDRyM{i=
CHL-1 M2rwc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF;KTo8yOCEQvF2= Mm\ZO|IhcA>? NYTjUmFZTE2VTx?= NEK4OFhKSzVyPUGwJO69VQ>? M2\wbVI{QDR2MEO4
Colo320DM NYPx[FhKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVjON3NHOTBizszN NVrLWmtZPzJiaB?= M4LBSGROW09? NGTyOZNKSzVyPUGwJO69VQ>? M4XQPVI{QDR2MEO4
Colo704 NVWxOI9oT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXi5bnRPOTBizszN M3e0bFczKGh? NYXTTHdTTE2VTx?= M{TzVWlEPTB;MUCg{txO M2GwcVI{QDR2MEO4
COR-L23 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3vTRVExKM7:TR?= M3rvTVczKGh? M4CzbmROW09? MljPTWM2OD1zMDFOwG0> NFP4clAzOzh2NECzPC=>
CRO-AP2 MoDwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnP1NVAh|ryP NWLNeGE6PzJiaB?= M17rSGROW09? NHzQTZFKSzVyPUGwJO69VQ>? NVzkd45lOjN6NESwN|g>
Daudi NWHQfGU{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXqxNEDPxE1? NV\TWlVoPzJiaB?= NEPDO5lFVVOR MUPJR|UxRTFyIN88US=> NX\FXoNoOjN6NESwN|g>
DOTC 24510 MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnTNNVAh|ryP MV:3NkBp NXLpW4pkTE2VTx?= MYLJR|UxRTFyIN88US=> MUOyN|g1PDB|OB?=
DU-145 NH7s[VhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXP3[2NFOTBizszN NHvFT|c4OiCq MUDEUXNQ MYrJR|UxRTFyIN88US=> NIW5PWQzOzh2NECzPC=>
EB-3 Mn70S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mn\YNVAh|ryP M{TvT|czKGh? MnHOSG1UVw>? M3j0UGlEPTB;MUCg{txO NFLjTHUzOzh2NECzPC=>
EFM-19 MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1jV[VExKM7:TR?= NVKzfm5zPzJiaB?= NWrEUXJOTE2VTx?= NV\K[pl3UUN3ME2xNEDPxE1? NF:0O5gzOzh2NECzPC=>
EKVX NFXaS2JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGLnemEyOCEQvF2= M3[3V|czKGh? M1e0dWROW09? NEPDUJNKSzVyPUGwJO69VQ>? NUPxRlNTOjN6NESwN|g>
FaDu NH\nS|BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUWxNEDPxE1? MlLzO|IhcA>? MkLOSG1UVw>? NXzBXmdGUUN3ME2xNEDPxE1? MoPDNlM5PDRyM{i=
G401 NUizO3lLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmPkNVAh|ryP NGPNPGQ4OiCq NEjYb21FVVOR MoDiTWM2OD1zMDFOwG0> Mlv6NlM5PDRyM{i=
HCC-70 NVLudodQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NY\PSIVUOTBizszN NUX0VHZJPzJiaB?= MoLXSG1UVw>? MknITWM2OD1zMDFOwG0> Mn\WNlM5PDRyM{i=
HCC-1954 Mni1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFTS[pQyOCEQvF2= M2XZcVczKGh? NH3YS3VFVVOR NV3kdHkyUUN3ME2xNEDPxE1? MoTONlM5PDRyM{i=
Hela NYq0UHduT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFjVUFIyOCEQvF2= MYi3NkBp Moe5SG1UVw>? MW\JR|UxRTFyIN88US=> NUj6bm1vOjN6NESwN|g>
Hep3B NIT2SldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MU[xNEDPxE1? NUf0PIVHPzJiaB?= M{[xbGROW09? MmXKTWM2OD1zMDFOwG0> Mmq0NlM5PDRyM{i=
HMCB NFfhd5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWixNEDPxE1? NYH5[nhpPzJiaB?= M4rtN2ROW09? MV;JR|UxRTFyIN88US=> NUPpbo9EOjN6NESwN|g>
HN5 M1Tre2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mk[yNVAh|ryP NXPH[5VrPzJiaB?= NIeyZpZFVVOR M3Lt[mlEPTB;MUCg{txO M1\XOFI{QDR2MEO4
HOS MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1ztZlExKM7:TR?= M4\v[lczKGh? M2PaXmROW09? NGTye2JKSzVyPUGwJO69VQ>? NFm5T4kzOzh2NECzPC=>
HPAF-II NHXpVW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4jGUFExKM7:TR?= NWPYcZhSPzJiaB?= MlnNSG1UVw>? M33tbmlEPTB;MUCg{txO MXGyN|g1PDB|OB?=
Hs746.T NVqxV|ZwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXjJU|VlOTBizszN NH31NXQ4OiCq MkHlSG1UVw>? NXqxTJBTUUN3ME2xNEDPxE1? Ml7jNlM5PDRyM{i=
HT MoK0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MW[xNEDPxE1? MWC3NkBp MmnISG1UVw>? NYPOeo5PUUN3ME2xNEDPxE1? MoW5NlM5PDRyM{i=
HT-3 MoToS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mlf1NVAh|ryP NUSzN21rPzJiaB?= MoWxSG1UVw>? NYHwNFVWUUN3ME2xNEDPxE1? MkHnNlM5PDRyM{i=
HuNS-1 Mlf6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFLIR2syOCEQvF2= NFrKWWY4OiCq M4LwNmROW09? Mmf0TWM2OD1zMDFOwG0> NH7XbmEzOzh2NECzPC=>
IGROV1 M1zxdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NE\QUHkyOCEQvF2= NXy5UIF2PzJiaB?= Mn30SG1UVw>? M{LhfWlEPTB;MUCg{txO NH:1VHkzOzh2NECzPC=>
J82 M2n6e2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MX[xNEDPxE1? NWD1[Gd4PzJiaB?= MVTEUXNQ NF3HTpNKSzVyPUGwJO69VQ>? NGTodZozOzh2NECzPC=>
JM1 NHLHUoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkjnNVAh|ryP MY[3NkBp NGC1e4lFVVOR NYHseolOUUN3ME2xNEDPxE1? MkHhNlM5PDRyM{i=
Kato III MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVqxNEDPxE1? NIrNe2U4OiCq M3z1OGROW09? NX;RRXFXUUN3ME2xNEDPxE1? MlLNNlM5PDRyM{i=
KHOS-240S MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn7yNVAh|ryP MWq3NkBp MnTjSG1UVw>? M{LnXGlEPTB;MUCg{txO NHWyS20zOzh2NECzPC=>
KM-12 NV;VOW1[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUn3bHl7OTBizszN NGPUNnc4OiCq NIi4R41FVVOR MV;JR|UxRTFyIN88US=> MlToNlM5PDRyM{i=
KPL-1 NF3B[3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWmxNEDPxE1? M2LNcVczKGh? NHfqOXJFVVOR NEm3[XVKSzVyPUGwJO69VQ>? NYC5U|BjOjN6NESwN|g>
KYSE-30 NXPLdGsxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2rqRlExKM7:TR?= NGq1T5U4OiCq MnuySG1UVw>? MkSxTWM2OD1zMDFOwG0> M{fQbVI{QDR2MEO4
LNCaP M4nhe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYCxNEDPxE1? M2DRRVczKGh? Ml25SG1UVw>? NHXURmNKSzVyPUGwJO69VQ>? MnrrNlM5PDRyM{i=
MCF-7 M1HQWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{n0T|ExKM7:TR?= MkLpO|IhcA>? NUnQRWFSTE2VTx?= NVfsbWpYUUN3ME2xNEDPxE1? MoHYNlM5PDRyM{i=
MC-IXC NVX3XpVrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml;1NVAh|ryP NWfqNYJ2PzJiaB?= MoDKSG1UVw>? M4exXWlEPTB;MUCg{txO Moe0NlM5PDRyM{i=
MDA-MB-175 VII M2\2Omdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1nRXFExKM7:TR?= M{HtV|czKGh? M1nWSWROW09? MVrJR|UxRTFyIN88US=> M3nnV|I{QDR2MEO4
MDA-MB-468 NYjlTmdLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXS4bodEOTBizszN NGDNNI44OiCq NIjkR5BFVVOR M3jzc2lEPTB;MUCg{txO M{jvcVI{QDR2MEO4
MiaPaCa MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVexNEDPxE1? MVi3NkBp NUTuT2Y3TE2VTx?= MU\JR|UxRTFyIN88US=> M1uyNlI{QDR2MEO4
Molt-4 NG[4V4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MorkNVAh|ryP NXfFfpB[PzJiaB?= NHyyRZdFVVOR M1S5UmlEPTB;MUCg{txO NGnLXoszOzh2NECzPC=>
NCI-ADR/RES MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmGwNVAh|ryP M1;3XFczKGh? NYfNZ5ZvTE2VTx?= MYTJR|UxRTFyIN88US=> M{C3WlI{QDR2MEO4
NCI-H69 NWrzN4V2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mmn1NVAh|ryP NVS4UFdbPzJiaB?= MUTEUXNQ MnnVTWM2OD1zMDFOwG0> MVmyN|g1PDB|OB?=
NCI-H82 MkDQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlTqNVAh|ryP MVO3NkBp MUPEUXNQ NWPyNGVYUUN3ME2xNEDPxE1? NEjSdo0zOzh2NECzPC=>
NCI-N87 NYDrTlljT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXGxNEDPxE1? MWK3NkBp NUfHenFVTE2VTx?= NEn2dYhKSzVyPUGwJO69VQ>? M4\pUlI{QDR2MEO4
NCI-H146 Mn\mS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mn7QNVAh|ryP NFTBfZk4OiCq MkHNSG1UVw>? MoXzTWM2OD1zMDFOwG0> MYOyN|g1PDB|OB?=
NCI-H157 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIm2N5kyOCEQvF2= NIPxVo44OiCq M1zI[WROW09? NVLCOlFEUUN3ME2xNEDPxE1? MmfwNlM5PDRyM{i=
NCI-H187 MlrDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{XY[|ExKM7:TR?= Ml7UO|IhcA>? MmfiSG1UVw>? MoTHTWM2OD1zMDFOwG0> Mo\yNlM5PDRyM{i=
NCI-H209 MmHaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWWxNEDPxE1? NFzpbXY4OiCq NFzsTJJFVVOR M2jZeWlEPTB;MUCg{txO MlzLNlM5PDRyM{i=
NCI-H226 NWjXZ4RyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVWxNEDPxE1? NYW1WHNRPzJiaB?= NEfKZ4pFVVOR NW\jTWZ6UUN3ME2xNEDPxE1? MlPENlM5PDRyM{i=
NCI-H292 MlnWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlLpNVAh|ryP MoHlO|IhcA>? M3ThcmROW09? MkDkTWM2OD1zMDFOwG0> M{C1blI{QDR2MEO4
NCI-H322 NI[xWINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2DwT|ExKM7:TR?= NVXHb2dHPzJiaB?= NF6xdotFVVOR MVjJR|UxRTFyIN88US=> MlTXNlM5PDRyM{i=
NCI-H358 Mm\mS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXqxNEDPxE1? NF\CRok4OiCq MnLPSG1UVw>? NXTsWJRLUUN3ME2xNEDPxE1? M4nyVlI{QDR2MEO4
NCI-H520 M3zne2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHnoUXUyOCEQvF2= NWDpUmRFPzJiaB?= MXPEUXNQ NHfPTVBKSzVyPUGwJO69VQ>? Ml64NlM5PDRyM{i=
NCI-H526 NX;mRlU2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1HOT|ExKM7:TR?= Mny3O|IhcA>? NIS0e4FFVVOR NILw[IFKSzVyPUGwJO69VQ>? M1TkelI{QDR2MEO4
NCI-H630 NXe3SGY6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3vwPFExKM7:TR?= Mo[1O|IhcA>? M3zm[2ROW09? NW\jSFNCUUN3ME2xNEDPxE1? NH;2emwzOzh2NECzPC=>
NCI-H661 M4rNe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4LPfVExKM7:TR?= MYG3NkBp NETucWZFVVOR M3;LNWlEPTB;MUCg{txO Mkm4NlM5PDRyM{i=
NCI-H716 MofLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGPW[HMyOCEQvF2= M1O0flczKGh? NGLZTW5FVVOR MmnqTWM2OD1zMDFOwG0> MUeyN|g1PDB|OB?=
NCI-H1563 NGrVdYJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEXre3gyOCEQvF2= NYDRcml4PzJiaB?= MUXEUXNQ M1fsPGlEPTB;MUCg{txO M1nhfVI{QDR2MEO4
NCI-H1792 NF33ZXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVrucnRxOTBizszN NGDrU244OiCq M1PKWGROW09? MVTJR|UxRTFyIN88US=> M1PzXlI{QDR2MEO4
NCI-H2030 NVH3bVZ1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NF7u[HIyOCEQvF2= M{PWPFczKGh? NXPRZVZ1TE2VTx?= MofKTWM2OD1zMDFOwG0> M2e4[VI{QDR2MEO4
NCI-H2052 M4DiWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHrPU|AyOCEQvF2= NHOySok4OiCq MnqySG1UVw>? MYDJR|UxRTFyIN88US=> MnjVNlM5PDRyM{i=
NCI-H2122 NG\xW5pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVz2U4x1OTBizszN M4n3XlczKGh? M3zK[2ROW09? MX;JR|UxRTFyIN88US=> M4LlbFI{QDR2MEO4
NCI-H2228 NF;UTmpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1Pae|ExKM7:TR?= M37sUFczKGh? MnTJSG1UVw>? NHvWd2ZKSzVyPUGwJO69VQ>? NIHl[28zOzh2NECzPC=>
OE-19 NUDxcmNZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYexNEDPxE1? NFTJOYY4OiCq NVjSU4dZTE2VTx?= NF3Ib3hKSzVyPUGwJO69VQ>? MkHoNlM5PDRyM{i=
OE-21 MmTaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIrmXHMyOCEQvF2= MmPZO|IhcA>? Ml\mSG1UVw>? NHL4XJNKSzVyPUGwJO69VQ>? NVjUcXA2OjN6NESwN|g>
OE-33 M1f4b2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NI\uTZYyOCEQvF2= NXr1d2ZvPzJiaB?= MoLsSG1UVw>? NXnvTpZvUUN3ME2xNEDPxE1? MYSyN|g1PDB|OB?=
OVCAR-3 NF;YR4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoTSNVAh|ryP M1rGXFczKGh? NIK5PHJFVVOR NFWwbJVKSzVyPUGwJO69VQ>? MkfwNlM5PDRyM{i=
OVCAR-4 NVL3enA5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkjFNVAh|ryP MVS3NkBp MX\EUXNQ MoHjTWM2OD1zMDFOwG0> NV7VTJhrOjN6NESwN|g>
OVCAR-5 M{m0SGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2LOOVExKM7:TR?= Mn;CO|IhcA>? M{\DbWROW09? NVrnSmtCUUN3ME2xNEDPxE1? M2XpVFI{QDR2MEO4
P3HR-1 MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUK4VJU3OTBizszN M2j0N|czKGh? MVHEUXNQ NHvJZ5VKSzVyPUGwJO69VQ>? M{f4dFI{QDR2MEO4
PC-3 NFy1NZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXrqdlJ1OTBizszN M2Hyb|czKGh? NYH5fGM1TE2VTx?= M1\FOGlEPTB;MUCg{txO MX[yN|g1PDB|OB?=
Raji MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHrIPI0yOCEQvF2= M3ruOlczKGh? MmXRSG1UVw>? M4nSfGlEPTB;MUCg{txO MoGzNlM5PDRyM{i=
RD NHXVdGNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGLoRlQyOCEQvF2= M1KwVFczKGh? NWSwTWZFTE2VTx?= NEnsNZlKSzVyPUGwJO69VQ>? MlLYNlM5PDRyM{i=
RD-ES NFTtd5BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUC2UYp{OTBizszN NWHIPJgyPzJiaB?= NHPBeZlFVVOR NXTCOHhUUUN3ME2xNEDPxE1? MUOyN|g1PDB|OB?=
RL NVr2eIRqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH\sSlQyOCEQvF2= Mn6zO|IhcA>? MXzEUXNQ NYDRVJg6UUN3ME2xNEDPxE1? NEHoNJgzOzh2NECzPC=>
SaOS2 MnzqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWexNEDPxE1? M3zBe|czKGh? M1X4fGROW09? NXXGdW9wUUN3ME2xNEDPxE1? M1XSdlI{QDR2MEO4
SCC-9 NX7WXmNUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXOxNEDPxE1? M1jF[FczKGh? MljHSG1UVw>? NUnHVVBwUUN3ME2xNEDPxE1? MmPvNlM5PDRyM{i=
SCC-12 NEjKNpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXexNEDPxE1? MY[3NkBp NGfjUplFVVOR NXPxbIVXUUN3ME2xNEDPxE1? MWmyN|g1PDB|OB?=
SCC-13 M4i1XWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWPRb21LOTBizszN MmTRO|IhcA>? M3PRfmROW09? MYPJR|UxRTFyIN88US=> M3HOUFI{QDR2MEO4
SCC-15 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYWxNEDPxE1? MVq3NkBp MV;EUXNQ Mn70TWM2OD1zMDFOwG0> Ml;GNlM5PDRyM{i=
SCC-25 MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2rIS|ExKM7:TR?= NYPIO25qPzJiaB?= MXrEUXNQ NHXYcopKSzVyPUGwJO69VQ>? Mny4NlM5PDRyM{i=
SCLC-3 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYexNEDPxE1? NFTITYY4OiCq MnTrSG1UVw>? MkDVTWM2OD1zMDFOwG0> M4\nPFI{QDR2MEO4
SF-268 NYKzb5h5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWWydHZJOTBizszN NYTTW4hxPzJiaB?= MnPSSG1UVw>? NW\OcGhzUUN3ME2xNEDPxE1? NX3FVlhWOjN6NESwN|g>
SF-295 MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX;WWW1LOTBizszN NYfrVYJEPzJiaB?= MVjEUXNQ NIPIOVdKSzVyPUGwJO69VQ>? NHjoS4gzOzh2NECzPC=>
SJRH30 NIXXU|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIr3R|kyOCEQvF2= NHrlZYk4OiCq MUHEUXNQ NIPm[mFKSzVyPUGwJO69VQ>? M3vBcVI{QDR2MEO4
SK-BR-3 NEPm[ndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1PMWVExKM7:TR?= MnvTO|IhcA>? NVflO3dZTE2VTx?= MnLCTWM2OD1zMDFOwG0> MVWyN|g1PDB|OB?=
SK-LMS-1 M2rZNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MojRNVAh|ryP MmnzO|IhcA>? NELsflZFVVOR MnfBTWM2OD1zMDFOwG0> NYH5NGhUOjN6NESwN|g>
SK-N-DZ MkSyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGrIOncyOCEQvF2= MX63NkBp MUnEUXNQ NXj5RYptUUN3ME2xNEDPxE1? NVnRUmtWOjN6NESwN|g>
SK-N-F1 NEHNTm1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUSxNEDPxE1? NIriTYk4OiCq NVzRXXM5TE2VTx?= MVzJR|UxRTFyIN88US=> NXHQSFd3OjN6NESwN|g>
SKOV-3 M2Pzemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVjpcHJQOTBizszN NYfOU|ZYPzJiaB?= MljKSG1UVw>? NFTqNYhKSzVyPUGwJO69VQ>? NUfPVHFsOjN6NESwN|g>
SK-UT-1 NEPGc|JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXOxNEDPxE1? MnnXO|IhcA>? MlXlSG1UVw>? M{W1[2lEPTB;MUCg{txO NUj1TnZpOjN6NESwN|g>
SN12C M4HxcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV[xNEDPxE1? Mn7MO|IhcA>? NHvPXXdFVVOR M1[5emlEPTB;MUCg{txO MXKyN|g1PDB|OB?=
SNB-19 NX:5VXlpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX2xNEDPxE1? MVS3NkBp MmPPSG1UVw>? NFnIN2NKSzVyPUGwJO69VQ>? MV[yN|g1PDB|OB?=
SNU-5 MmjKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2OxbVExKM7:TR?= MUe3NkBp MWfEUXNQ M2r6UWlEPTB;MUCg{txO MnPUNlM5PDRyM{i=
SNU-16 NGfVWXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlLxNVAh|ryP NVvFSVdUPzJiaB?= MnX0SG1UVw>? M2\uNWlEPTB;MUCg{txO NX3Tc2RbOjN6NESwN|g>
SNU-398 M{Lrdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXGxNEDPxE1? NEKxfYk4OiCq NV3wS|NOTE2VTx?= NF30TolKSzVyPUGwJO69VQ>? NIP1fYIzOzh2NECzPC=>
SNU-449 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mki4NVAh|ryP MoXlO|IhcA>? M{DSeGROW09? MkfETWM2OD1zMDFOwG0> MlOzNlM5PDRyM{i=
SR MojMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEC3b3YyOCEQvF2= MUW3NkBp MnP2SG1UVw>? NX[0To45UUN3ME2xNEDPxE1? NH;2ZoUzOzh2NECzPC=>
ST486 MkfuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYSxNEDPxE1? Mlm5O|IhcA>? MnLPSG1UVw>? NIfuTVVKSzVyPUGwJO69VQ>? NVTUNYM3OjN6NESwN|g>
SW579 M{m3WWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2TrUVExKM7:TR?= M3nmOFczKGh? NGLmcIVFVVOR M4rwfmlEPTB;MUCg{txO MmS5NlM5PDRyM{i=
SW684 NXzuUWlNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYCxNEDPxE1? NXzOSFVUPzJiaB?= NIXXfpdFVVOR M13ndmlEPTB;MUCg{txO NHe4R4ozOzh2NECzPC=>
SW-780 NGTiWHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3zTdVExKM7:TR?= MVy3NkBp NUjHWGZbTE2VTx?= M3X3S2lEPTB;MUCg{txO NED6ZYgzOzh2NECzPC=>
SW900 M2XHemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUixNEDPxE1? NEntOHU4OiCq MXTEUXNQ MXnJR|UxRTFyIN88US=> M{n4bFI{QDR2MEO4
SW1088 M3XkTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIjHdpIyOCEQvF2= M{ntV|czKGh? NXHvdW9bTE2VTx?= NHrwWYtKSzVyPUGwJO69VQ>? NIDqVlQzOzh2NECzPC=>
SW1463 MmXhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYexNEDPxE1? NUK5c|VbPzJiaB?= M2\kcGROW09? NHrid4hKSzVyPUGwJO69VQ>? MW[yN|g1PDB|OB?=
SW1990 NEPhS3dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUG4UY9VOTBizszN M1y3[VczKGh? MYjEUXNQ MYjJR|UxRTFyIN88US=> MWCyN|g1PDB|OB?=
T47D Mnv3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVzORVFmOTBizszN M3HRSVczKGh? MnfzSG1UVw>? M3flOWlEPTB;MUCg{txO MV6yN|g1PDB|OB?=
TE381.T NHPyWWJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX:1bW5jOTBizszN Ml;IO|IhcA>? Mn7ISG1UVw>? MUPJR|UxRTFyIN88US=> NFfwd|AzOzh2NECzPC=>
TK-10 MlrzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXHxXY5OOTBizszN M4\yS|czKGh? NVKzeFh7TE2VTx?= MUTJR|UxRTFyIN88US=> MlLUNlM5PDRyM{i=
U2OS MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXmwS5BJOTBizszN M2PScVczKGh? NXfsfZFITE2VTx?= NGn2WZZKSzVyPUGwJO69VQ>? NGnYSXozOzh2NECzPC=>
U251 NUTFUGlVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlOwNVAh|ryP MlrqO|IhcA>? NH7xSmVFVVOR NIGyc3dKSzVyPUGwJO69VQ>? MYWyN|g1PDB|OB?=
UACC-812 M4GwTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoXmNVAh|ryP NFHwSVk4OiCq Mmq3SG1UVw>? M1HtS2lEPTB;MUCg{txO M4HGTlI{QDR2MEO4
YAPC M4DhZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3m1VVExKM7:TR?= M{CyNlczKGh? NVP1V5U2TE2VTx?= M{XmNWlEPTB;MUCg{txO NW\RcVJ1OjN6NESwN|g>
ZR-75-1 M4nhT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF3welEyOCEQvF2= M3vPWlczKGh? Mme2SG1UVw>? M{Ho[GlEPTB;MUCg{txO NITmWmkzOzh2NECzPC=>
A375 Ml7rSpVv[3Srb36gZZN{[Xl? NFzJXVAyNjJizszN MVm0JIg> Mo\tSG1UVw>? M{jVWmlvcGmkaYTpc44hd2ZicHjvd5Bpd3K7bHH0bY9vKG:oIF3FT{whTVKNLDDhcoQhWz[S MnziNlI{QDl2N{G=
YUSIT1 NXzQ[49NTnWwY4Tpc44h[XO|YYm= NXO5To15TE2VTx?= NH\JSodz\WS3Y3XkJJNmdnOrdHn2bZR6KHerdHigTWM2OCB-IECuOUDPxE1? NH\z[YczOjN6OUS3NS=>
MeWo MVPHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? NFPRWI1FVVOR NF[zfldKSzVyIE2gPVg4KG6P M2LlRlI3ODF6NUK0
WiDr M1\tS2dzd3e2aDDpcohq[mm2aX;uJIF{e2G7 M2nxTmROW09? MYfJR|UxKD1iN{[gcm0> NF3wcYQzPjBzOEWyOC=>
Colo-205 NET0d|dHfW6ldHnvckBie3OjeR?= Mn\ONUDPxE1? Ml;NOEBl MWXEUXNQ NWXHc3FlUW6mdXPl[EBiKGirZ3jsfUBkd22yYYLhZoxmKGOxbYDhZ5Rqd25icHjlco91gXCn M2raV|I2OzhzMUWy
RBW-1 NWPzdplCTnWwY4Tpc44h[XO|YYm= MX[xJO69VQ>? M3vMdGROW09? MYDOc{Bz\WS3Y4Tpc44hd2ZiTXXrJFEwOiCyaH;zdIhwenmuYYTpc44> NH2wW20zPDh6NU[5NC=>
RBO-1 NFjudmNHfW6ldHnvckBie3OjeR?= NVjhVYp3OSEQvF2= NGi3VmpFVVOR NHf2TmNKdmirYnn0bY9vKG:oIF3lb{AyNzJicHjvd5Bpd3K7bHH0bY9v Mn\tNlQ5QDV4OUC=
RBO-2 NUnLOnJ1TnWwY4Tpc44h[XO|YYm= NEH4TZAyKM7:TR?= MX3EUXNQ NGPIWYVKdmirYnn0bY9vKG:oIDDN[YshOS9{IIDoc5NxcG:{eXzheIlwdg>? MXGyOFg5PTZ7MB?=
RBOW NITMTnJHfW6ldHnvckBie3OjeR?= NFm1NYkyKM7:TR?= NYjINWMxTE2VTx?= NWjvbmpkUW6qaXLpeIlwdiCxZjCgUYVsKDFxMjDwbI9{eGixconsZZRqd25? M3L0NlI1QDh3Nkmw
M257 MoDvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXKxNFAhdk1? MYG3NkBp MXrEc4V{KG6xdDDpcohq[mm2IIDyc4xq\mW{YYTpc44hd2ZiTUK1O{Bk\WyuIHjhdoJwfXKrbnege4lt\CC2eYDlJGJTSUZ? M3XBW|I{OzF5NES2
LCP NEnDOlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MljiNVAxKG6P MU[3NkBp NEX4cYFKdmirYnn0bY9vKG:oIIDyc4xq\mW{YYTpc44hd2ZiTFPQJINmdGxiaHHyZo92emmwZzDCVmFHKFZ4MEDSJI12fGGwdHH0bY9v M1rVNlI{OzF5NES2
WM266 NWW4fXZrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVqxNFAhdk1? NFnUPIM4OiCq Mk\5TY5pcWKrdHnvckBw\iCycn;sbYZmemG2aX;uJI9nKFePMk[2JINmdGxiaHHyZo92emmwZzDCVmFHKFZ4MEHEJI12fGGwdHH0bY9v MWSyN|MyPzR2Nh?=
M257 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoPwNVAxKG6P MWW3NkBp NH7HWoVFd2W|IH7veEBqdmirYnn0JGVTUzFvMjDwbI9{eGixconsZZRqd25iaX6gUVI2PyClZXzsJIhiemKxdYLpcochf2muZDD0fZBmKEKUQV[= NHOwSXUzOzNzN{S0Oi=>
LCP M{\TR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2fNNFExOCCwTR?= NGr5SIE4OiCq M2W5bGlvcGmkaYSgSXJMOS1{IIDoc5NxcG:{eXzheIlwdiCrbjDMR3Ah[2WubDDoZZJjd3W{aX7nJGJTSUZiVk[wNHIhdXW2YX70ZZRqd25? MVKyN|MyPzR2Nh?=
WM266 NWjrSHd6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXSxNFAhdk1? M1XiXVczKGh? NWTMW2tDUW6qaXLpeEBGWktzLUKgdIhwe3Cqb4L5cIF1cW:wIHnuJHdOOjZ4IHPlcIwhcGG{Yn;1dolv\yCEUlHGJHY3ODCGIH31eIFvfGG2aX;u NVrHR3N[OjN|MUe0OFY>

... Click to View More Cell Line Experimental Data

In vivo Dabrafenib (orally administrated) inhibits the growth of B-RafV600E mutant melanoma (A375P) and colon cancer (Colo205) human tumor xenografts, growing subcutaneously in immuno-compromised mice. [1]

Protocol

Solubility (25°C)

In vitro DMSO 30 mg/mL (57.74 mM)
Water Insoluble
Ethanol Insoluble
In vivo Add solvents individually and in order:
30% PEG400+0.5% Tween80+5% propylene glycol
8 mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 519.56
Formula

C23H20F3N5O2S2

CAS No. 1195765-45-7
Storage powder
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT01723202 Active, not recruiting Follicular Thyroid Cancer|Insular Thyroid Cancer|Papillary Thyroid Cancer|Recurrent Thyroid Cancer Manisha Shah|National Comprehensive Cancer Network|Ohio State University Comprehensive Cancer Center November 7, 2012 Phase 2
NCT02672358 Not yet recruiting Non-Small-Cell Lung Cancer Novartis Pharmaceuticals|Novartis October 2017 Phase 2
NCT02447939 Withdrawn Melanoma GlaxoSmithKline May 2017 Phase 1
NCT02967692 Not yet recruiting Melanoma Novartis Pharmaceuticals|Novartis February 2017 Phase 3
NCT02858921 Not yet recruiting Melanoma Melanoma Institute Australia|Merck Sharp & Dohme Corp.|Novartis February 2017 Phase 2
NCT03026517 Recruiting Melanoma Memorial Sloan Kettering Cancer Center|Massachusetts General Hospital|Weill Medical College of Cornell University January 2017 Phase 1

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Related Antibodies

Raf Signaling Pathway Map

Raf Inhibitors with Unique Features

Related Raf Products

Tags: buy Dabrafenib (GSK2118436) | Dabrafenib (GSK2118436) supplier | purchase Dabrafenib (GSK2118436) | Dabrafenib (GSK2118436) cost | Dabrafenib (GSK2118436) manufacturer | order Dabrafenib (GSK2118436) | Dabrafenib (GSK2118436) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID